Back to Trades
Total Value
$425.9K
Filing Date
Jun 18, 2026
1 transactions
Trade Summary
On Jun 17, 2026, Loy Spike, Director, reported $425.9K of MoonLake Immunotherapeutics (MLTX) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $19.19. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- MoonLake Immunotherapeutics
- Ticker Symbol
- MLTX
- CIK
- 0001821586
Insider Information
- Name
- Loy Spike
- Role
- Director
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- Jun 17, 2026
- Accession Number
- 0001213900-26-070257
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | MLTX derivative | 22,195 | $19.19 | Grant/Award | $425.9K |
Want live alerts when Loy Spike trades again?
Download Insider Trades to track MLTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This option represents a right to purchase a total of 22,195 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.